Lecture 13 Drug Testing

0.0(0)
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
Card Sorting

1/16

encourage image

There's no tags or description

Looks like no tags are added yet.

Study Analytics
Name
Mastery
Learn
Test
Matching
Spaced

No study sessions yet.

17 Terms

1
New cards

How many phases of premarket clinical trials?

3 phases

2
New cards

Fast track for drugs in what situation?

serious condition with unmet need

3
New cards

Breakthrough therapy for drugs in what situation?

- substantial improvement of a drug in safety, efficacy, compliance of a drug

4
New cards

Accelerated approval of a drug based on what?

surrogate endpoint, not actual disease/therapy outcome

5
New cards

Priority review in drug approval based on what?

significant improvement in some area of a drug

6
New cards

Purpose of phase I of drug testing

Safety trial -- not for efficacy of the drug but to make sure if drug is used at designed dosing range in young, healthy people that it is reasonably safe

7
New cards

Purpose of phase II trial

test the efficacy of the drug for intended purpose--emphasizes near perfect compliance and adherence to treatment

8
New cards

Phase III trial purpose

effectiveness trial for drugs mimicking real clinical practice

9
New cards

How long do drug companies get patent protection for a developed drug?

10 years

10
New cards

How can companies extend patent protection of their drug?

pure enantiomers

11
New cards

Each drug has 3 types of names

- chemical
- generic/non-proprietary
- trade/proprietary

12
New cards

Does FDA require additional testing for generic drugs? Biosimilar drugs?

No, yes

13
New cards

Does FDA in USA regulate how doctors use drugs?

no

14
New cards

Why are some drugs taken off market after FDA approval?

- missed toxicity (rare side effects)
- drug interactions
- non-compliance
- manufacture problem

15
New cards

Withdrawal of drugs explain

- Manufacturer voluntarily chooses to withdraw batch of product b/c of minor violation -- not FDA. violation

16
New cards

Recall of drugs explain

FDA initiates this due to significant patient endangerment

17
New cards

Black box labeling

FDA issues additional warnings for therapeutic agents